These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18484142)
1. The effects of endothelin receptor blockade by bosentan on the healing of a bowel anastomosis in an experimental Crohn's disease model. Kirkil C; Cetinkaya Z; Ustundag B; Akpolat N; Ayten R; Bulbuller N J Gastrointest Surg; 2008 Aug; 12(8):1429-35. PubMed ID: 18484142 [TBL] [Abstract][Full Text] [Related]
2. An orally active non-selective endothelin receptor antagonist, bosentan, markedly reduces injury in a rat model of colitis. Hogaboam CM; Muller MJ; Collins SM; Hunt RH Eur J Pharmacol; 1996 Aug; 309(3):261-9. PubMed ID: 8874149 [TBL] [Abstract][Full Text] [Related]
3. Effect of the combination of fibrin glue and growth hormone on intestinal anastomoses in a pig model of traumatic shock associated with peritonitis. Wang P; Wang J; Zhang W; Li Y; Li J World J Surg; 2009 Mar; 33(3):567-76. PubMed ID: 19132439 [TBL] [Abstract][Full Text] [Related]
4. Adrenocorticotrophic hormone-induced hypertension in the rat: effects of the endothelin antagonist bosentan. Fraser TB; Mangos GJ; Turner SW; Whitworth JA Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):628-33. PubMed ID: 10474778 [TBL] [Abstract][Full Text] [Related]
5. Endothelin blockade in angiotensin II hypertension: prevention and treatment studies in the rat. Ficai S; Herizi A; Mimran A; Jover B Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1100-3. PubMed ID: 11903325 [TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984 [TBL] [Abstract][Full Text] [Related]
7. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y; Oliver JR; Horowitz JD Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [TBL] [Abstract][Full Text] [Related]
8. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Herrero I; Torras J; Riera M; Condom E; Coll O; Cruzado JM; Hueso M; Bover J; Lloberas N; Alsina J; Grinyó JM Nephrol Dial Transplant; 1999 Apr; 14(4):872-80. PubMed ID: 10328462 [TBL] [Abstract][Full Text] [Related]
9. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney. Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712 [TBL] [Abstract][Full Text] [Related]
10. Role of platelet-rich fibrin on intestinal anastomosis wound healing in a rat. Özçay N; Özdemir H; Besim H Biomed Mater; 2018 Apr; 13(4):045006. PubMed ID: 29565259 [TBL] [Abstract][Full Text] [Related]
11. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity. Lazaratos S; Nakahara A; Goto K; Fukutomi H Life Sci; 1995; 56(9):PL195-200. PubMed ID: 7869843 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats. Richard V; Hogie M; Thuillez C Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056 [TBL] [Abstract][Full Text] [Related]
15. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917 [TBL] [Abstract][Full Text] [Related]
16. The role of endothelin-1 and endothelin receptor antagonists in allergic rhinitis inflammation: ovalbumin-induced rat model. Tatar A; Yayla M; Kose D; Halici Z; Yoruk O; Polat E Rhinology; 2016 Sep; 54(3):266-72. PubMed ID: 27016898 [TBL] [Abstract][Full Text] [Related]
17. Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats. Jara A; von Höveling A; Jara X; Burgos ME; Valdivieso A; Mezzano S; Felsenfeld AJ Nephrol Dial Transplant; 2006 Apr; 21(4):917-23. PubMed ID: 16431896 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Martin C; Held HD; Uhlig S Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):128-36. PubMed ID: 10961375 [TBL] [Abstract][Full Text] [Related]
20. Endothelin antagonism with bosentan: current status and future perspectives. Ono K; Matsumori A Cardiovasc Drug Rev; 2002; 20(1):1-18. PubMed ID: 12070530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]